Medicinal Products

EMERADE Gé 150 micrograms Injectable IM box of 2 pre-filled pens of 015 mL

Generic drug from Epipen
Therapeutic class: Allergology
Active ingredients: Adrenaline, Adrenaline, Adrenaline
laboratory: Chauvin

IM Injectable Solution
All forms

Indication

EMERADE is indicated for the emergency treatment of severe acute allergic reactions (anaphylactic shock) caused by allergens in foods, drugs, insect bites and bites, and other allergens, as well as for the treatment of allergens. anaphylactic shock induced by idiopathic stress or anaphylactic shock.

Dosage EMERADE Ge 150 micrograms Injectable IM box of 2 pre-filled pens of 015 mL

EMERADE is indicated for the emergency treatment of severe acute allergic reactions (anaphylactic shock) caused by allergens in foods, drugs, insect bites and bites, and other allergens, as well as for the treatment of allergens. anaphylactic shock induced by idiopathic stress or anaphylactic shock.

Against indications

There is no absolute contraindication to the use of EMERADE in an allergic emergency.

Undesirable effects Emerade Gé

The adverse effects of adrenaline are generally associated with its activity on alpha- and beta-adrenergic receptors.

The following chart is based on the experience of using adrenaline.

Adverse reactions are categorized by frequency as follows:

· Very common (≥ 1/10)

· Frequent (≥ 1/100 to <1/10)

· Uncommon (≥ 1/1000 to <1/100)

· Rare (≥ 1/10 000 to <1/1000)

· Very rare (<1 / 10, 000)

· Not known (can not be estimated from the available data)

Classes of organ systems

Frequency

Adverse reactions

Metabolism and nutrition disorders

Not known frequency

Hyperglycemia, hypokalemia, acidosis

Psychiatric disorders

Not known frequency

Anxiety, hallucinations

Central nervous system disorders

Not known frequency

Headache, vertigo, tremors, syncope

Heart conditions

Not known frequency

Tachycardia, arrhythmia, palpitations, angina pectoris, stress cardiomyopathy

Vascular disorders

Not known frequency

Hypertension, vasoconstriction, peripheral ischemia

Respiratory, thoracic and mediastinal disorders

Not known frequency

bronchospasm

Gastrointestinal disorders

Not known frequency

Nausea, vomiting

General disorders and administration site conditions

Not known frequency

Hyperhidrosis, asthenia

EMERADE contains sodium metabisulphite, which in rare cases may cause severe hypersensitivity reactions (see Warnings and Precautions ) section.

Reporting of suspected adverse reactions

The reporting of suspected adverse reactions after authorization of the drug is important. It allows continuous monitoring of the benefit / risk ratio of the drug. Health professionals declare any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.

Popular Posts

Category Medicinal Products, Next Article